Physician profile
Michael Jones
NPI 1013020080
$9,361.87
in general payments reported to CMS, 2019-2025
15 companies · $1,524 in 2025
The $1,524 reported for 2025 was more than what 81% of Surgery of The Hand (Plastic Surgery) providers received nationally (typical 2025 total: $312).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,175 · 2020: $21.90 · 2021: $19.42 · 2022: $2,505 · 2023: $3,946 · 2024: $170 · 2025: $1,524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,041 · Food and Beverage: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,040.54 |
| Food and Beverage | $599.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ensemble Orthopedics, INC | $6,340.00 | 2022-2024 | Ensemble Cmc |
| Trimed, INC. | $1,367.37 | 2025 | |
| Medinc of Texas | $1,103.00 | 2019 | |
| Acumed LLC | $147.38 | 2023 | Acumed |
| Axogen | $114.50 | 2019-2025 | |
| Anika Therapeutics, INC. | $73.17 | 2024 | Integrity, Tactoset, X-Twist |
| Vertex Pharmaceuticals Incorporated | $61.38 | 2024-2025 | |
| Depuy Synthes Sales INC. | $27.15 | 2025 | Monovisc, Orthovisc |
| Ethicon US, LLC | $27.07 | 2024 | Vistaseal, Stratafix, Dermabond Prineo |
| Heron Therapeutics, INC. | $24.63 | 2021-2022 | |
| Kerecis Limited | $21.41 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Conformis, INC. | $18.82 | 2019 | |
| Biogen, INC. | $17.60 | 2020 | |
| Avanos Medical | $14.09 | 2019 | |
| Orthofix Medical, INC. | $4.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.